Safety and efficacy of a programmed cell death 1 inhibitor combined with oxaliplatin plus S-1 in patients with Borrmann large type III and IV gastric cancers
Article in World Journal of Gastrointestinal Oncology (April 2024)
The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.
Article in World Journal of Gastrointestinal Oncology (April 2024)
Article in International Journal of Clinical Oncology (March 2024)
Article in Translational Cancer Research (March 2024)